FDA risk category C includes drugs with adverse effects in animal studies but no adequate human studies, used when maternal benefit justifies the risk; this category includes most drugs (60-70%), such as gabapentin, amlodipine, trazodone, GLP-1 agonists, some SSRIs, and short-term narcotic use.